{
  "Disease_Characteristics": {
    "Initial_Gleason_Score": null,
    "PSA_at_diagnosis": null,
    "TNM_stage": null,
    "Metastatic_site": null,
    "Number_of_metastatic_sites": null
  },
  "Biomarkers_Genetics": {
    "Androgen_Receptor_Status": null,
    "BRCA1_2_status": null,
    "Other_mutations": [],
    "PSMA_expression": null
  },
  "Treatment_History": {
    "First_line_therapy": null,
    "Response_to_first_line": null,
    "Subsequent_therapies": [],
    "Treatment_duration_months": null,
    "Treatment_resistance": null
  },
  "Clinical_Outcomes": {
    "PSA_response_percent_change": null,
    "Radiographic_response": null,
    "Progression_Free_Survival_months": null,
    "Overall_Survival_months": null,
    "Adverse_events": []
  },
  "Quality_of_Life_Symptoms": {
    "Pain_score": null,
    "Performance_status": null,
    "Bone_pain": null,
    "Fatigue": null
  }
}
